- Stents Market are small, expandable mesh tubes inserted into narrowed or blocked coronary arteries to restore and maintain blood flow to the heart. These stents are vital in the treatment of coronary artery disease (CAD), which results from the buildup of plaque in the arterial walls. By physically supporting the artery and releasing medications in the case of drug-eluting stents, they help prevent restenosis, improve heart function, and reduce the risk of heart attacks, thereby enhancing patient outcomes and quality of life.
- Japan emerges as a leading region in the Asia-Pacific Stents Market , supported by a highly developed healthcare infrastructure, widespread awareness of cardiovascular diseases, and strong reimbursement frameworks for interventional cardiology procedures.
- The region’s ongoing investments in advanced stent technologies, such as bioresorbable scaffolds and next-generation drug-eluting stents, coupled with an aging population and high prevalence of CAD, continue to fuel market growth and innovation in coronary stent therapies.
- Drug Eluting Stent (DES) segment is expected to dominate the market with a market share of 68.7%, due to its proven effectiveness in reducing restenosis and the need for repeat interventions in patients undergoing percutaneous coronary interventions. Advances in stent technology, such as the development of newer, more biocompatible drug coatings and improved delivery systems, have enhanced the safety and efficacy of DES. Additionally, the rising prevalence of cardiovascular diseases worldwide, along with increasing adoption of minimally invasive procedures, has further propelled the demand for DES, establishing it as the preferred choice in interventional cardiology.
